Skip to main content

Alnylam Pharmaceuticals, Inc. - Common Stock (NQ: ALNY )

245.44 +6.57 (+2.75%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
January 19, 2012
Form 8-K
Source: SEC/Edgar
January 16, 2012
Form 8-K
Source: SEC/Edgar
January 08, 2012
Form CT ORDER
Source: SEC/Edgar
December 19, 2011
Form 8-K
Source: SEC/Edgar
November 09, 2011
Form 8-K
Source: SEC/Edgar
October 31, 2011
Form EFFECT
Source: SEC/Edgar
August 18, 2011
Form 8-K
Source: SEC/Edgar
July 31, 2011
Form CT ORDER
Source: SEC/Edgar
July 24, 2011
Form S-3
Source: SEC/Edgar
July 20, 2011
Form 8-K
Source: SEC/Edgar
June 28, 2011
Form 8-K
Source: SEC/Edgar
June 12, 2011
Form 8-K
Source: SEC/Edgar
June 09, 2011
Form 8-K
Source: SEC/Edgar
June 06, 2011
Form CT ORDER
Source: SEC/Edgar
May 17, 2011
Form CT ORDER
Source: SEC/Edgar
May 11, 2011
Form ARS
Source: SEC/Edgar
May 04, 2011
Form 8-K
Source: SEC/Edgar
May 01, 2011
Form DEF 14A
Source: SEC/Edgar
May 01, 2011
Form 8-K
Source: SEC/Edgar
April 06, 2011
Form 8-K
Source: SEC/Edgar
March 24, 2011
Form 8-K
Source: SEC/Edgar
March 22, 2011
Form CT ORDER
Source: SEC/Edgar
March 21, 2011
Form 8-K
Source: SEC/Edgar
March 16, 2011
Form 8-K
Source: SEC/Edgar
March 14, 2011
Form 8-K
Source: SEC/Edgar
March 02, 2011
Form S-8
Source: SEC/Edgar
February 17, 2011
Form 8-K
Source: SEC/Edgar
February 16, 2011
Form SC 13G/A
Source: SEC/Edgar
February 13, 2011
Form SC 13G/A
Source: SEC/Edgar
February 13, 2011
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.